UNC13D Antibody | CSB-PA758222LA01HU

(No reviews yet) Write a Review
SKU:
CSB-PA758222LA01HU
Availability:
3 to 7 Working Days
  • UNC13D Antibody
  • Immunohistochemistry of paraffin-embedded human lung tissue using CSB-PA758222LA01HU at dilution of 1:100
  • Immunofluorescent analysis of Hela cells using CSB-PA758222LA01HU at dilution of 1:100 and Alexa Fluor 488-congugated AffiniPure Goat Anti-Rabbit IgG (H+L)
€315.80 - €488.70

Description

UNC13D Antibody | CSB-PA758222LA01HU | Cusabio

UNC13D Antibody is Available at Gentaur Genprice with the fastest delivery.

Online Order Payment is possible or send quotation to info@gentaur.com.

Product Type: Polyclonal Antibody

Target Names: UNC13D

Aliases: Protein unc-13 homolog D (Munc13-4), UNC13D

Background: Plays a role in cytotoxic granule exocytosis in lymphocytes. Required for both granule maturation and granule docking and priming at the immunologic synapse. Regulates assembly of recycling and late endosomal structures, leading to the formation of an endosomal exocytic compartment that fuses with perforin-containing granules at the immunologic synapse and licences them for exocytosis. Regulates Ca (2+) -dependent secretory lysosome exocytosis in mast cells.

Isotype: IgG

Conjugate: Non-conjugated

Clonality: Polyclonal

Uniport ID: Q70J99

Host Species: Rabbit

Species Reactivity: Human

Immunogen: Recombinant Human Protein unc-13 homolog D protein (7-172AA)

Immunogen Species: Human

Applications: ELISA, IHC, IF

Tested Applications: ELISA, IHC, IF; Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200

Purification Method: >95%, Protein G purified

Dilution Ratio1: ELISA:1:2000-1:10000

Dilution Ratio2: IHC:1:20-1:200

Dilution Ratio3: IF:1:50-1:200

Dilution Ratio4:

Dilution Ratio5:

Dilution Ratio6:

Buffer: Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4

Form: Liquid

Storage: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Initial Research Areas: Immunology

Research Areas: Immunology

View AllClose

0 Reviews

View AllClose